Clinical performance of the BioFire Blood Culture Identification 2 panel for microorganism species identification and resistance gene detection in blood culture-positive specimens
PLOS One · 05.06.2026 · 21 (6) · e0350768
DOI: 10.1371/journal.pone.0350768 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 05.06.2026. Verfasst von Haruki Naruse und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory, Saitama Medical University International Medical Center, Saitama, Japan. Hauptthemen laut MEDLINE: Blood Culture, Drug Resistance, Bacterial, Bacteria, Bacteremia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hidaka Research Project Grant.
Abstract (Originalsprache)
Introduction
Bloodstream infections are life-threatening, and the rapid identification of pathogens and resistance genes is essential for the administration of appropriate antimicrobial agents. The BioFire Blood Culture Identification 2 (BCID2) panel on the FilmArray multi-parameter genetic analyzer is a fully automated PCR test that rapidly identifies species and resistance genes. Here, we compared the performance of the Filmarray BCID2 panel (BCID2 method) with the conventional method.
Methods
Among the blood culture-positive specimens submitted between January 2023 and November 2024, this study analyzed 201 specimens that contained the target microorganisms of the BCID2 panel. In our laboratory, after subculturing the culture medium obtained from a positive blood-culture bottle, we perform species identification using mass spectrometry and drug susceptibility testing (the conventional method). We compared the results of the BCID2 method with those of the conventional method.
Results
Concordance between the BCID2 and conventional methods was found in 152 of the 161 monomicrobial specimens (94.4%) and in 31 of the 40 polymicrobial specimens (77.5%). The 18 specimens that were discordant were mostly matched at the genus level, but the BCID2 method also detected other microorganisms that were not identified by the conventional method. Resistance genes were identified in 57 of the 61 matched specimens (93.4%).
Conclusion
The BCID2 method exhibits excellent identification results and resistance gene detection rates, suggesting that it is a reliable and rapid diagnostic test system for bloodstream infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Laboratory, Saitama Medical University International Medical Center, Saitama, Japan.
- Department of Laboratory Medicine, Saitama Medical University International Medical Center, Saitama, Japan.
ORCID-Profile: Yasuhiro Ebihara
Förderung
- Hidaka Research Project Grant
Zitieren
APA
Naruse, H., Watanabe, N., Koyama, S., Tanaka, S., Taji, Y., & Ebihara, Y. (2026). Clinical performance of the BioFire Blood Culture Identification 2 panel for microorganism species identification and resistance gene detection in blood culture-positive specimens. PLOS One, 21(6), e0350768. https://doi.org/10.1371/journal.pone.0350768
Vancouver
Naruse H, Watanabe N, Koyama S, Tanaka S, Taji Y, Ebihara Y. Clinical performance of the BioFire Blood Culture Identification 2 panel for microorganism species identification and resistance gene detection in blood culture-positive specimens. PLOS One. 2026;21(6):e0350768. doi:10.1371/journal.pone.0350768
BibTeX
@article{Naruse2026,
author = {Naruse, Haruki and Watanabe, Noriyuki and Koyama, Sachie and Tanaka, Sachi and Taji, Yoshitada and Ebihara, Yasuhiro},
title = {Clinical performance of the BioFire Blood Culture Identification 2 panel for microorganism species identification and resistance gene detection in blood culture-positive specimens},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {6},
pages = {e0350768},
doi = {10.1371/journal.pone.0350768}
}
EUVIMED